Condition

Stage III Pancreatic Neuroendocrine Tumor AJCC v8 clinical trials and research

• 2Clinical trials
• 4Countries

All recruiting trials (2)

• Combining Sunitinib with Lutetium Lu 177 Dotatate for Pancreatic Neuroendocrine Tumors

  This study is testing if combining two treatments, sunitinib and lutetium Lu 177 dotatate, can help people with advanced pancreatic neuroendocrine tumors live longer and feel better.

  Recruiting at 8 sites Phase 1 National Cancer Institute (NCI) · Duarte, California and 9 other locations · NCT05687123

• Using chemotherapy after surgery for high-risk pancreatic neuroendocrine tumors

  This study tests if a combination of two chemotherapy drugs can help prevent cancer from coming back in people who have had surgery for high-risk pancreatic neuroendocrine tumors.

  Recruiting at 381 sites Phase 2 SWOG Cancer Research Network · Anchorage, Alaska and 447 other locations · NCT05040360

Related topics

Quick answers

How many Stage III Pancreatic Neuroendocrine Tumor AJCC v8 clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (2 trials), Mexico (1 trial), Uruguay (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →